United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of ~~The~~ the

Securities Exchange Act of 1934

December 3 10, 2020

Date of Report (Date of earliest event reported)

Tottenham Acquisition I Limited

(Exact Name of Registrant as Specified in its Charter)

British Virgin Islands		001-38614		n/a
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

Unit 902, Lucky Building 39-41 Wellington Street, Central, Hong Kong		n/a
Unit 902, Lucky Building 39-41 Wellington Street Central, Hong Kong		n/a
(Address of Principal Executive Offices)		(Zip Code)

Registrant's telephone number, including area code: +852 3998 4852

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act

☒	Soliciting material pursuant to Rule 14a-12 under the Exchange Act

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Ordinary Share, par value $.0001 per share, one Redeemable Warrant to acquire one-half of one Ordinary Share, and one Right to acquire one-tenth (1/10) of an Ordinary Share	TOTAU	NASDAQ Capital Market
Ordinary Shares	TOTA	NASDAQ Capital Market
Warrants	TOTAW	NASDAQ Capital Market
Rights	TOTAR	NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Item 1.01.~~IMPORTANT ~~Entry into a Material Definitive Agreement.~~NOTICES

~~The disclosure~~Important ~~contained~~Notice inRegarding ~~Item 2.03 is incorporated by reference in this Item 1.01~~Forward-Looking Statements

~~Item~~This Current Report on Form 8-K contains 2certain “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended.03 ~~Creation~~Statements that are not historical facts, including statements about the pending transactions among Tottenham Acquisition I Limited (“Tottenham”), Chelsea Worldwide Inc. (“Purchaser”), Creative Worldwide Inc. (“Merger Sub”), and Clene Nanomedicine, Inc. (“Clene”) and the transactions contemplated thereby, and the parties’ perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transaction, including the anticipated initial enterprise value and post-closing equity value, the benefits of athe proposed ~~Direct~~transaction, ~~Financial~~integration ~~Obligation~~plans, orexpected ansynergies ~~Obligation~~and ~~under~~revenue anopportunities, ~~Off~~anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, and the expected timing of the transactions. The words “expect,” “believe,” “estimate,” “intend,” “plan” and similar expressions indicate forward-~~Balance~~looking ~~Sheet~~statements. ~~Arrangement~~These forward-looking statements are not guarantees of afuture ~~Registrant~~performance and are subject to various risks and uncertainties, assumptions (including assumptions about general economic, market, industry and operational factors), known or unknown, which could cause the actual results to vary materially from those indicated or anticipated.

OnSuch risks and uncertainties include, ~~December~~but 3are not limited to: (i) risks related to the expected timing and likelihood of completion of the pending transaction, ~~2020~~including the risk that the transaction may not close due to one or more closing conditions to the transaction not being satisfied or waived, such ~~Tottenham~~as ~~Acquisition~~regulatory Iapprovals ~~Limited~~not (being obtained, on a timely basis or otherwise, or that a governmental entity prohibited, delayed or refused to grant approval for the ~~“Company”)~~consummation ~~issued~~of anthe ~~unsecured~~transaction ~~promissory~~or ~~note~~required certain conditions, limitations or restrictions in connection with such approvals; (ii) risks related to the ~~aggregate~~ability of Tottenham and Clene to successfully integrate the businesses; ~~principal~~(iii) ~~amount~~the occurrence of ~~$115~~any event,~~028.27~~ (change or other circumstances that could give rise to the ~~“Note”~~termination of the applicable transaction agreements; (iv) the risk that there may be a material adverse change with respect to ~~Norwich~~the ~~Investment~~financial ~~Limited~~position, ~~the~~performance, ~~Company’s~~operations or ~~initial~~prospects ~~public~~of ~~offering~~Clene or Tottenham; (v) risks related to disruption of management time from ongoing business operations due to ~~sponsor~~the proposed transaction; (~~“Norwich”~~vi) inthe ~~exchange~~risk ~~for~~that ~~Norwich~~any ~~depositing~~announcements ~~such~~relating ~~amount~~to ~~into~~the proposed transaction could have adverse effects on the ~~Company~~market price of Tottenham’s ~~trust~~securities; ~~account~~(vii) inthe ~~order~~risk that the proposed transaction and its announcement could have toan ~~extend~~adverse effect on the ~~amount~~ability of ~~time~~Clene and Tottenham to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on their operating results and businesses generally; (viii) the risk that the combined company may be unable to achieve cost-cutting synergies or it ~~has~~may ~~available~~take longer than expected to ~~complete~~achieve athose ~~business~~synergies; ~~combination~~and (ix) risks associated with the financing of the proposed transaction. ~~The~~A ~~Note~~further ~~does~~list ~~not~~and ~~bear~~description ~~interest~~of risks and ~~mature~~uncertainties ~~upon~~can be found ~~closing~~in ofTottenham’s aAnnual ~~business~~Report ~~combination~~on byForm 10-K for the ~~Company.~~fiscal Inyear ~~addition~~ending December 31, 2019 filed with the ~~Note~~SEC, ~~may~~in beTottenham’s quarterly ~~converted~~reports byon Form 10-Q filed with the ~~holder~~SEC ~~into~~subsequent ~~units~~thereto ofand in the ~~Company~~Registration Statement on Form S-4 and proxy statement ~~identical~~filed towith the ~~units~~SEC ~~issued~~by the Purchaser in connection with the ~~Company’s~~proposed ~~initial~~transactions, ~~public~~and ~~offering~~other atdocuments athat ~~price~~the parties may file or furnish with the SEC, which you are encouraged to read. Should one or more of ~~$10~~these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements.00 ~~per~~Accordingly, ~~unit~~you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and Tottenham, Purchaser, Merger Sub, Clene, and their subsidiaries undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

Item 8.01 Other Events

The Company issued the release filed herewith on December 4, 2020. The materials attached as Exhibit 99.1 are incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.		Description
99.1		Press Release dated December 4, 2020

~~SIGNATURES~~Additional Information and Where to Find It

~~Pursuant to~~In connection with the ~~requirements~~transaction ofdescribed herein, Tottenham and Purchaser filed relevant materials with the Securities and Exchange ~~Act~~Commission of(the ~~1934~~“SEC”), including the ~~Registrant~~Registration ~~has~~Statement ~~duly~~on ~~caused~~Form ~~this~~S-4 ~~report~~and a proxy statement. The proxy statement and a proxy card will be mailed to stockholders as of a record date to be ~~signed~~established for voting at the stockholders’ meeting relating to the proposed transactions. Stockholders will also be able to obtain a copy of the Registration Statement on ~~its~~Form ~~behalf~~S-4 and proxy statement without charge from the Company. byThe Registration Statement on Form S-4 and proxy statement, once available, may also be obtained without charge at the ~~undersigned~~SEC’s website ~~hereunto~~at ~~duly~~www.sec.gov ~~authorized~~or by writing to Tottenham at Unit 902, Lucky Building, 39-41 Wellington Street, Central, Hong Kong. INVESTORS AND SECURITY HOLDERS OF TOTTENHAM ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE TRANSACTIONS THAT TOTTENHAM WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT TOTTENHAM, CLENE AND THE TRANSACTIONS.

~~Dated: December~~Participants 4,in ~~2020~~Solicitation

~~TOTTENHAM~~Tottenham, ~~ACQUISITION~~Purchaser, IMerger ~~LIMITED~~Sub, ~~By:~~Clene, certain /shareholders of the Company, and their respective directors, executive officers and employees and other persons may be deemed to be participants in the solicitation of proxies from the holders of Tottenham ordinary shares in respect of the proposed transaction. Information about Tottenham’s~~/Jason~~ Madirectors ~~Name:~~and ~~Jason~~executive Maofficers ~~Title:~~and ~~Chief~~their ~~Executive~~ownership ~~Officer~~of Tottenham’s ordinary shares is set forth in Tottenham’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC. Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement pertaining to the proposed transaction when it becomes available. These documents can be obtained free of charge from the sources indicated above.

Item 7.01 Regulation FD Disclosure

On December 10, 2020, Clene announced the presentation of blinded interim results from the Phase 2 RESCUE-ALS clinical trial investigating the effects of its lead clinical candidate, CNM-Au8, for the treatment of amyotrophic lateral sclerosis (ALS). Copy of the press releases is attached hereto as Exhibit 99.1.

The foregoing information, including the press release attached hereto as Exhibit 99.1 is being furnished pursuant to Item 7.01 of this Current Report and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.		Description
99.1		Clene Press Release, dated December 10, 2020

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: December 10, 2020

TOTTENHAM ACQUISITION I LIMITED

By:	/s/ Jason Ma
Name:	Jason Ma
Title:	Chief Executive Officer

Filing Compare · Tottenham Acquisition I Ltd